60
Participants
Start Date
September 6, 2020
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
Elezanumab
Solution for infusion; Intravenous (IV)
Placebo
Solution for infusion; Intravenous (IV)
Royal Adelaide Hospital /ID# 216953, Adelaide
Complejo Hospitalario Universitario A Coruña /ID# 216384, A Coruña
Ajou University Hospital /ID# 241119, Suwon
Thomas Jefferson University Hospital /ID# 215460, Philadelphia
Duplicate_Inha University Hospital /ID# 238890, Junggu
University of Virginia Health /ID# 218117, Charlottesville
Virginia Commonwealth University Medical Center Main Hospital /ID# 217481, Richmond
Sentara Norfolk General Hospital /ID# 218302, Norfolk
West Virginia University Hospitals /ID# 217344, Morgantown
Hospital Universitario 12 de Octubre /ID# 225354, Madrid
University of Louisville Hospital /ID# 215948, Louisville
Hospital Universitario Virgen del Rocio /ID# 225692, Seville
Hospital Nacional de Paraplejicos /ID# 225508, Toledo
Hospital Universitario y Politecnico La Fe /ID# 217797, Valencia
Wisconsin Medical Center /ID# 215610, Milwaukee
Washington University-School of Medicine /ID# 215325, St Louis
University of California Davis Health /ID# 224892, Sacramento
Oregon Medical Research Center /ID# 227371, Portland
National Hospital Organization Murayama Medical Center /ID# 223492, Musashimurayama-shi
The Chaim Sheba Medical Center /ID# 240917, Ramat Gan
Shepherd Center, Inc /ID# 230370, Atlanta
Northwestern University Feinberg School of Medicine /ID# 218009, Chicago
Duplicate_Tufts Medical Center /ID# 225410, Boston
Brigham & Women's Hospital /ID# 216342, Boston
Boston University School of Medicine /ID# 218371, Boston
Beth Israel Deaconess Medical Center /ID# 218149, Boston
Regents of the University of Michigan /ID# 215890, Ann Arbor
Hackensack Univ Med Ctr /ID# 215754, Hackensack
Jersey Shore University Medical Center /ID# 218162, Neptune City
Rutgers New Jersey School of Medicine /ID# 216212, Newark
Duke Cancer Center /ID# 216888, Durham
University of Pennsylvania /ID# 218662, Philadelphia
Foothills Medical Centre /ID# 214790, Calgary
Duplicate_QEII - Health Sciences Centre /ID# 215249, Halifax
The Ottawa Hospital Civic Campus /ID# 215270, Ottawa
Toronto Western Hospital /ID# 215214, Toronto
CIUSSS du Nord-de-l'ile-de-Montréal_Hopital du Sacré-Coeur de Montréal /ID# 215210, Montreal
NHO Nagoya Medical Center /ID# 239617, Nagoya
Funabashi Municipal Medical Center /ID# 225599, Funabashi-shi
Japan Organization of Occupational Health and Safety Spinal Injuries Centre /ID# 224141, Iizuka-shi
Hospital Universitario Vall d'Hebron /ID# 217794, Barcelona
Lead Sponsor
AbbVie
INDUSTRY